S. Gantz

A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer.

D. Venzon, F. Balis, B. Widemann, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Hematopoietic growth factors.

M. Woolery-Antill, S. Gantz, L. DeLaPena, 1996, Cancer nursing.

Effect of raloxifene on bone mineral density in premenopausal women at increased risk of breast cancer.

D. Venzon, D. Danforth, J. Zujewski, 2006, The Journal of clinical endocrinology and metabolism.

Programmed Instruction: Biotherapy Module V: Hematopoietic Growth Factors

M. Woolery-Antill, S. Gantz, L. DeLaPena, 1996 .

A phase I trial of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in hormone-receptor positive metastatic breast cancer.

M. Merino, F. Balis, B. Widemann, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.